Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flynn

Showing results (1121-1130 of 1,203) with videos related to

Pageof 121
Sort By:
The Journal of Infectious Diseases|September 28, 2011
Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancerSilvana Carr, Kim J Allison, Lee-Ann Van De Velde, et al.
AIDS and Behavior|June 5, 2017
Lessons Learned From the Implementation of Seek, Test, Treat, Retain Interventions Using Mobile Phones and Text Messaging to Improve Engagement in HIV Care for Vulnerable Populations in the United StatesKaterina A Christopoulos, William E Cunningham, Curt G Beckwith, et al.
Leukemia|January 22, 2014
The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia modelK A Beckwith, F W Frissora, M R Stefanovski, et al.
Journal of Clinical Medicine|March 25, 2022
Thoracic Curve Correction Ratio: An Objective Measure to Guide against Overcorrection of a Main Thoracic Curve in the Setting of a Structural Proximal Thoracic CurveMatthew R Landrum, Andrew H Milby, Burt Yaszay, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|December 13, 2016
Factors affecting the outcome in appearance of AIS surgery in terms of the minimal clinically important differenceJames T Bennett, Amer F Samdani, Tracey P Bastrom, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 15, 2003
Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitorW Ross Tracey, Judith L Treadway, William P Magee, et al.
Leukemia & Lymphoma|February 12, 2015
Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphomaFarrukh T Awan, Joseph M Flynn, Jeffrey A Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2018
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment TrialAlejandro Arenas-Pinto, Birgit Grund, Shweta Sharma, et al.
AIDS (London, England)|August 3, 2019
Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with menCatherine N Le, Paula Britto, Sean S Brummel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trialPeter L Havens, Charles B Stephensen, Rohan Hazra, et al.
Pageof 121

Showing results (1121-1130 of 1,203) with videos related to

Sort By:
Pageof 121
The Journal of Infectious Diseases|September 28, 2011
Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancerSilvana Carr, Kim J Allison, Lee-Ann Van De Velde, et al.
AIDS and Behavior|June 5, 2017
Lessons Learned From the Implementation of Seek, Test, Treat, Retain Interventions Using Mobile Phones and Text Messaging to Improve Engagement in HIV Care for Vulnerable Populations in the United StatesKaterina A Christopoulos, William E Cunningham, Curt G Beckwith, et al.
Leukemia|January 22, 2014
The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia modelK A Beckwith, F W Frissora, M R Stefanovski, et al.
Journal of Clinical Medicine|March 25, 2022
Thoracic Curve Correction Ratio: An Objective Measure to Guide against Overcorrection of a Main Thoracic Curve in the Setting of a Structural Proximal Thoracic CurveMatthew R Landrum, Andrew H Milby, Burt Yaszay, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|December 13, 2016
Factors affecting the outcome in appearance of AIS surgery in terms of the minimal clinically important differenceJames T Bennett, Amer F Samdani, Tracey P Bastrom, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 15, 2003
Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitorW Ross Tracey, Judith L Treadway, William P Magee, et al.
Leukemia & Lymphoma|February 12, 2015
Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphomaFarrukh T Awan, Joseph M Flynn, Jeffrey A Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2018
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment TrialAlejandro Arenas-Pinto, Birgit Grund, Shweta Sharma, et al.
AIDS (London, England)|August 3, 2019
Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with menCatherine N Le, Paula Britto, Sean S Brummel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trialPeter L Havens, Charles B Stephensen, Rohan Hazra, et al.
Pageof 121